300 related articles for article (PubMed ID: 34863080)
101. DT-13 inhibits the proliferation of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.
Xie G; Tong F; Xu M; Shu Y; Li Z
Biochem Biophys Res Commun; 2024 Feb; 695():149451. PubMed ID: 38176173
[TBL] [Abstract][Full Text] [Related]
102. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle K; LaComb JF; Graves LM; Baines AT; Bialkowska AB
PLoS One; 2023; 18(11):e0294065. PubMed ID: 37943821
[TBL] [Abstract][Full Text] [Related]
103. Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
Sun C; Liu X; Sun N; Zhang X; Shah M; Zhang G; Che Q; Zhu T; Li J; Li D
J Nat Prod; 2022 Apr; 85(4):987-996. PubMed ID: 35380848
[TBL] [Abstract][Full Text] [Related]
104. Vitamin C Suppresses Pancreatic Carcinogenesis through the Inhibition of Both Glucose Metabolism and Wnt Signaling.
Kim JH; Hwang S; Lee JH; Im SS; Son J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293106
[TBL] [Abstract][Full Text] [Related]
105. Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.
Duluc C; Moatassim-Billah S; Chalabi-Dchar M; Perraud A; Samain R; Breibach F; Gayral M; Cordelier P; Delisle MB; Bousquet-Dubouch MP; Tomasini R; Schmid H; Mathonnet M; Pyronnet S; Martineau Y; Bousquet C
EMBO Mol Med; 2015 Jun; 7(6):735-53. PubMed ID: 25834145
[TBL] [Abstract][Full Text] [Related]
106. Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter gamma-aminobutyric acid.
Al-Wadei HA; Plummer HK; Schuller HM
Carcinogenesis; 2009 Mar; 30(3):506-11. PubMed ID: 19131543
[TBL] [Abstract][Full Text] [Related]
107. LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer.
Feng M; Xiong G; Cao Z; Yang G; Zheng S; Qiu J; You L; Zheng L; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2018 Nov; 37(1):274. PubMed ID: 30419950
[TBL] [Abstract][Full Text] [Related]
108. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis.
Cheng T; Zhang Z; Shen H; Jian Z; Li J; Chen Y; Shen Y; Dai X
J Nanobiotechnology; 2020 Sep; 18(1):126. PubMed ID: 32891174
[TBL] [Abstract][Full Text] [Related]
109. Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells.
Chiu CF; Chang HY; Huang CY; Mau CZ; Kuo TT; Lee HC; Huang SY
Molecules; 2021 Apr; 26(9):. PubMed ID: 33923185
[TBL] [Abstract][Full Text] [Related]
110. Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Kageyama S; Kawauchi A; Inoue H
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982789
[TBL] [Abstract][Full Text] [Related]
111. Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin.
Shields MA; Spaulding C; Metropulos AE; Khalafalla MG; Pham TND; Munshi HG
Cell Rep; 2022 Mar; 38(9):110441. PubMed ID: 35235808
[TBL] [Abstract][Full Text] [Related]
112. Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.
Choi YS; Kim MJ; Choi EA; Kim S; Lee EJ; Park MJ; Kim MJ; Kim YW; Ahn HS; Jung JY; Jang G; Kim Y; Kim H; Kim K; Kim JY; Hong SM; Kim SC; Chang S
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2119048119. PubMed ID: 35858411
[TBL] [Abstract][Full Text] [Related]
113. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5.
Akuetteh PDP; Huang H; Wu S; Zhou H; Jin G; Hong W; Yang H; Lan L; Shangguan F; Zhang Q
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23192. PubMed ID: 35929395
[TBL] [Abstract][Full Text] [Related]
114. Synergistic effect of antagonists to KRas4B/PDE6 molecular complex in pancreatic cancer.
Briseño-Díaz P; Schnoor M; Bello-Ramirez M; Correa-Basurto J; Rojo-Domínguez A; Arregui L; Vega L; Núñez-González E; Palau-Hernández LA; Parra-Torres CG; García Córdova OM; Zepeda-Castilla E; Torices-Escalante E; Domínguez-Camacho L; Xoconostle-Cazares B; Meraz-Ríos MA; Delfín-Azuara S; Carrión-Estrada DA; Villegas-Sepúlveda N; Hernández-Rivas R; Thompson-Bonilla MDR; Vargas M
Life Sci Alliance; 2023 Dec; 6(12):. PubMed ID: 37813486
[TBL] [Abstract][Full Text] [Related]
115. Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model.
Le TQ; Meesiripan N; Sanggrajang S; Suwanpidokkul N; Prayakprom P; Bodhibukkana C; Khaowroongrueng V; Suriyachan K; Thanasitthichai S; Srisubat A; Surawongsin P; Rungsipipat A; Sakarin S; Rattanapinyopituk K
Sci Rep; 2024 Mar; 14(1):6515. PubMed ID: 38499634
[TBL] [Abstract][Full Text] [Related]
116. Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model.
Jabarin A; Shtar G; Feinshtein V; Mazuz E; Shapira B; Ben-Shabat S; Rokach L
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647152
[TBL] [Abstract][Full Text] [Related]
117. Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer.
Sun T; Peng H; Mao W; Ma L; Liu H; Mai J; Jiao L
Int J Biol Sci; 2021; 17(13):3634-3645. PubMed ID: 34512171
[TBL] [Abstract][Full Text] [Related]
118. Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.
Carbone D; De Franco M; Pecoraro C; Bassani D; Pavan M; Cascioferro S; Parrino B; Cirrincione G; Dall'Acqua S; Sut S; Moro S; Gandin V; Diana P
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233482
[TBL] [Abstract][Full Text] [Related]
119. Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis.
Xu D; Liu A; Liu Q; Zhang H; Tian M; Bian Y; Zhang X; Ying M; Shen H
Biochem Pharmacol; 2023 Nov; 217():115810. PubMed ID: 37717690
[TBL] [Abstract][Full Text] [Related]
120. Nutrient restriction-activated Fra-2 promotes tumor progression via IGF1R in miR-15a downmodulated pancreatic ductal adenocarcinoma.
Rampioni Vinciguerra GL; Capece M; Reggiani Bonetti L; Nigita G; Calore F; Rentsch S; Magistri P; Ballarin R; Di Benedetto F; Distefano R; Cirombella R; Vecchione A; Belletti B; Baldassarre G; Lovat F; Croce CM
Signal Transduct Target Ther; 2024 Feb; 9(1):31. PubMed ID: 38342897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
